Return to homepagePandemic Pact

Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: 3UM1AI068636-14S2

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2020
    2020

  • Known Financial Commitments (USD)

    $181,942,638

  • Funder

    National Institutes of Health (NIH)

  • Principal Investigator

    PROFESSOR Judith Currier

  • Research Location

    United States of America

  • Lead Research Institution

    UNIVERSITY OF CALIFORNIA LOS ANGELES

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Therapeutics logistics and supply chains and distribution strategies

  • Special Interest Tags

    N/A

  • Study Type

    N/A

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    N/A

  • Vulnerable Population

    N/A

  • Occupations of Interest

    N/A

Abstract

To more safely and efficiently treat COVID-19 participants, we request support to place COVID-19 Isolation PODS at 14 of the ACTG CRSs. The storage company, PODS, has developed stand-alone and CDC compliant units. Installation of a COVID-19 POD at CRS locations will primarily facilitate A5401 but also protocol A5395. These units additionally allow separation between these activities and our HIV patients for both COVID treatment and prevention studies. A5401 will study up to 10 different agents across phase 2 and phase 3 trials. This dedicated space will allow for efficient treatment of a high volume of study participants without comprising infection control measures of the general clinic population.